Compounds > deferoxamine

deferoxamine and camptothecin

deferoxamine has been researched along with camptothecin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Brockman, RW1
Ashcroft, M; Taya, Y; Vousden, KH1
Ando, M; Hanioka, N; Jinno, H; Nishimura, T; Ozawa, S; Sawada Ji, J; Tanaka-Kagawa, T1
Bertozzi, D; Capranico, G; Iurlaro, R; Marinello, J; Sordet, O; Zaffaroni, N1

Reviews

1 review(s) available for deferoxamine and camptothecin

ArticleYear
Biochemical aspects of drug combinations.
    Cancer chemotherapy reports. Part 2, 1974, Volume: 4, Issue:1

    Topics: Alkylating Agents; Animals; Antineoplastic Agents; Bleomycin; Camptothecin; Cell Division; Cytarabine; Deferoxamine; Diamines; DNA, Neoplasm; Doxorubicin; Drug Therapy, Combination; Leukemia L1210; Macromolecular Substances; Mice; Neoplasms; Neoplasms, Experimental; Nitrosourea Compounds; Purine Nucleotides; Ribonucleotide Reductases; Thioguanine; Triazoles

1974

Other Studies

4 other study(ies) available for deferoxamine and camptothecin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Stress signals utilize multiple pathways to stabilize p53.
    Molecular and cellular biology, 2000, Volume: 20, Issue:9

    Topics: Blotting, Northern; Camptothecin; Cells, Cultured; Chelating Agents; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Dactinomycin; Deferoxamine; Down-Regulation; Enzyme Inhibitors; Fibroblasts; Humans; Immunoblotting; Microscopy, Fluorescence; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors; Phosphorylation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Serine; Stress, Physiological; Time Factors; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2000
Interaction of irinotecan (CPT-11) and its active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38) with human cytochrome P450 enzymes.
    Drug metabolism and disposition: the biological fate of chemicals, 2002, Volume: 30, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; Binding, Competitive; Camptothecin; Catalase; Cell Line; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Deferoxamine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Glutathione; Humans; Irinotecan; Isoenzymes; Microsomes; Mixed Function Oxygenases; Protein Binding

2002
Characterization of novel antisense HIF-1α transcripts in human cancers.
    Cell cycle (Georgetown, Tex.), 2011, Sep-15, Volume: 10, Issue:18

    Topics: Camptothecin; Cell Fractionation; Cloning, Molecular; Deferoxamine; Female; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; HCT116 Cells; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; In Situ Hybridization, Fluorescence; Kidney Neoplasms; Male; Membrane Glycoproteins; Neoplasm Grading; Nuclear Envelope; Nuclear Pore Complex Proteins; RNA, Antisense; RNA, Untranslated; Transcriptional Activation

2011